Osteogenic Neoplasm — Trials

Osteogenic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

357 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–64 of 64 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00093080	Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)	completed	Phase 2	216	Merck Sharp & Dohme LLCINDUSTRY	0	Feb 13, 2015	clinicaltrials
NCT00331643	Ixabepilone in Treating Young Patients With Refractory Solid Tumors	completed	Phase 2	120	National Cancer Institute (NCI)NIH	1	Nov 14, 2014	clinicaltrials